Petgo

Petgo EBIT per Share

The EBIT per Share of Petgo (7140.T) as of Oct 22, 2026 is -108.26 JPY. In the previous year, EBIT per Share was 121.51 JPY — a change of -189.10% (lower).

EBIT per Share

-108.26JPY

YoY

-189.10%

Last updated:

EBIT per Share of Petgo is 2026 -108.26 JPY. EBIT per Share of Petgo was 2025 121.51 JPY. It decreases by -189.10% lower compared to the previous year.

The Petgo EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-2.11 JPY
Jan 1, 2021
52.97 JPY
Jan 1, 2022
88.46 JPY
Jan 1, 2023
124.21 JPY
Jan 1, 2024
131.95 JPY
Jan 1, 2025
121.51 JPY
Jan 1, 2026
-108.26 JPY
Jan 1, 2027 (e)
200.51 JPY
The Petgo EBIT per Share history
YEAREBIT per ShareYoY
est200.51JPY-285.22%
-108.26JPY-189.10%
121.51JPY-7.91%
131.95JPY+6.23%
124.21JPY+40.42%
88.46JPY+66.98%
52.97JPY-2,605.75%
-2.11JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Petgo Stock analysis

What does Petgo do? Petgo Corp. generates revenue by selling veterinary drugs, dietary foods, and supplements exclusively available at animal hospitals through its e-commerce platform petgo and other online malls. The company focuses on products such as flea and tick repellents, eye drops, dermatitis treatments, external otitis medicine, gastrointestinal medicine, and general nutrition foods for dogs and cats. Its primary customers are pet owners seeking specialized healthcare solutions for their pets, particularly those requiring prescription-only items typically sold at animal hospitals. The firm serves the pet healthcare segment within the e-commerce market, emphasizing convenience and access to restricted veterinary products. The business model centers on e-commerce sales of pet healthcare products, leveraging both its own online site petgo and partnerships with other online malls. Revenue streams come from the sale of veterinary drugs, dietary supplements, and care products, with a strong emphasis on items that are only available through animal hospitals. The company targets pet owners who prioritize professional-grade healthcare for their pets, avoiding generic pet product markets to maintain a niche focus. This approach allows Petgo Corp. to cater to a specific segment of the pet care industry that requires specialized medical products. Petgo Corp. operates within the pet healthcare sector, specifically focusing on e-commerce sales of prescription-only items like flea and tick repellents and gastrointestinal medicine. The company's product range includes veterinary drugs, dietary foods, and supplements, all sold through its online platform and other online malls. Its target market consists of pet owners who need access to animal hospital-exclusive products without visiting clinics, making it a convenient solution for ongoing pet healthcare needs. The firm's revenue is derived from direct sales of these specialized products, ensuring a steady income stream from a dedicated customer base. Petgo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Petgo stock

EBIT per Share of Petgo is -108.26 JPY in 2026.

EBIT per Share of Petgo changed from 121.51 JPY to -108.26 JPY, representing a -189.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Petgo since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Petgo

All Key Metrics — Petgo